62 Results for "

ADP-induced aggregation

" in MedChemExpress (MCE) Product Catalog:
Products (62)

62 Results for "ADP-induced aggregation" in MCE Product Catalog:

Cat. No.: HY-108633
CAS No.: 163120-31-8
Target:  

PARP

Research Areas:  

Cancer

AR-C66096 (FPL 66096) tetrasodium is a selective platelet P2YT receptor antagonist. AR-C66096 tetrasodium effectively blocks ADP-induced platelet aggregation. AR-C66096 tetrasodium can be used in the research of thromboembolism .
loading...
    loading...
Cat. No.: HY-19638AR
CAS No.: 163706-36-3
Synonyms: AR-C69931MX tetrasodium (Standard)
Cangrelor (tetrasodium) (Standard) is the analytical standard of Cangrelor (tetrasodium). This product is intended for research and analytical applications. Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist .
loading...
    loading...
Cat. No.: HY-W250153A
Adenosine 3'-phosphate 5'-phosphosulfate lithium hydrate, an adenine nucleotide derivative, is a selective P2Y1 antagonist with no effect on P2Y2, P2Y4, or P2Y6 receptors. Adenosine 3'-phosphate 5'-phosphosulfate lithium hydrate can competitive inhibit ADP-induced platelet aggregation, as well as the ability of ADP to cause shape change and increases in Ca 2+ in platelets, but had no effect on the inhibition of stimulated adenylate cyclase by ADP. Adenosine 3'-phosphate 5'-phosphosulfate lithium hydrate is a co-substrate used for the sulfonation of glycans. Adenosine 3'-phosphate 5'-phosphosulfate lithium hydrate can be used for Golgi-resident PAP-specific 3'-phosphatase-coupled sulfotransferase assays, which as donor substrate to transfer a sulfonate group .
loading...
    loading...
Cat. No.: HY-116850
CAS No.: 56611-65-5
Synonyms: EG626; Phthalazinol; SC-32840
Research Areas:  

Neurological Disease

Oxagrelate is a specific inhibitor of cyclic adenosine monophosphate phosphodiesterase and exhibits concentration-dependent inhibition of collagen- and ADP-induced platelet aggregation in vitro .
loading...
    loading...
Cat. No.: HY-P1702
CAS No.: 152323-73-4
Target:  

Integrin

Research Areas:  

Others

GR83895 is a RGD based peptide, and inhibits ADP-induced platelet aggregation of human gel-filtered platelets (IC50= 0.9 μM) .
loading...
    loading...
Cat. No.: HY-N13135
CAS No.: 2692637-23-1
Kadsutherin G (compound 3) is a lignin isolated from Kadsura. Kadsutherin G inhibits adenosine diphosphate (ADP)-induced platelet aggregation by 33.1 % .
loading...
    loading...
Cat. No.: HY-N13134
CAS No.: 2692637-03-7
Kadsutherin F (compound 2) is a lignin that can be isolated from Kadsura. Kadsutherin F has an inhibitory effect on adenosine diphosphate (ADP)-induced platelet aggregation with an inhibition rate of 49.47% .
loading...
    loading...
Cat. No.: HY-15284B
CAS No.: 389574-20-3
Synonyms: PCR 4099 (Maleic acid)
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease

Prasugrel (PCR 4099) Maleic acid is a thienopyridine and proagent, inhibits platelet function. Prasugrel Maleic acid is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-101370
CAS No.: 100020-57-3
Purity:  ≥98.0%
Target:  

P2X Receptor

Research Areas:  

Metabolic Disease

2-Methylthio-ATP tetrasodium is a non-specific P2-receptor agonist. 2-Methylthio-ATP tetrasodium causes noncompetitive inhibition of ADP-induced human platelet aggregation .
loading...
    loading...
Cat. No.: HY-113113
CAS No.: 19313-28-1
Synonyms: 13,14-Dihydroprostaglandin E1
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

13,14-Dihydro PGE1 is a metabolite of PGE1 (Prostaglandin E1) which inhibits the ADP-induced platelet aggregation (ID50 = 10.8 ng/mL platelet rich plasma) .
loading...
    loading...
Cat. No.: HY-N4266
CAS No.: 156042-22-7
Vinaginsenoside R8, a triterpenoid glycoside isolated from the rhizomes of Panacis majoris. Vinaginsenoside R8 displays activities against adenosine diphosphate (ADP)-induced platelet aggregation (IC50=25.18 μM) .
loading...
    loading...
Cat. No.: HY-136142
CAS No.: 1056459-37-0
Target:  

Drug Metabolite

Research Areas:  

Others

Prasugrel chloride impurity is a catp impurity of Prasugrel, exacted from patent US20130345428A1, line 0053. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-15284S1
CAS No.: 1127253-02-4
Purity:  98.58%
Synonyms: PCR 4099-d3
Prasugrel-d3 is the deuterium labeled Prasugrel. Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-122048
CAS No.: 164992-25-0
Synonyms: AR-C67085MX; PSB 0413; FPL 67085
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease

AR-C67085 (PSB 0413; FPL 67085) is a potent platelet P2T receptor antagonist with an pIC50 value of 8.60. AR-C67085 inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-15284S
CAS No.: 1127252-92-9
Synonyms: PCR 4099-d5
Prasugrel-d5 is deuterium labeled Prasugrel. Prasugrel (PCR 4099), a thienopyridine and prodrug, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-W419570
CAS No.: 478005-11-7
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease

(Rac)-BX 048 is a BX 048 racemate. BX 048 is a P2Y12 receptor antagonist. BX 048 inhibits ADP-induced platelet aggregation in human, dog and rat whole blood. BX 048 also inhibits Arachidonic acid (HY-109590) induced platelet aggregation (IC50 of 15 μM) .
loading...
    loading...
Cat. No.: HY-113723
CAS No.: 491611-43-9
Target:  

P2Y Receptor

Research Areas:  

Cardiovascular Disease

MRS2298? is a potent acyclic P2Y1 receptor antagonist with a Ki of 29.6 nM. MRS2298 inhibits the ADP-induced aggregation of human platelets with an IC50 of 62.8 nM. MRS2298 inhibits Ca 2+ rise in platelets with an IC50 of 810 nM .
loading...
    loading...
Cat. No.: HY-15284AR
CAS No.: 389574-19-0
Synonyms: PCR 4099 hydrochloride (Standard)
Research Areas:  

Cardiovascular Disease

Prasugrel (hydrochloride) (Standard) is the analytical standard of Prasugrel (hydrochloride). This product is intended for research and analytical applications. Prasugrel hydrochloride (PCR 4099 hydrochloride), a thienopyridine and proagent, inhibits platelet function. Prasugrel hydrochloride is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-15284R
CAS No.: 150322-43-3
Synonyms: PCR 4099 (Standard)
Research Areas:  

Cardiovascular Disease

Prasugrel (Standard) is the analytical standard of Prasugrel. This product is intended for research and analytical applications. Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...
Cat. No.: HY-15284S3
CAS No.: 1261394-83-5
Synonyms: PCR 4099-13C6
Prasugrel-13C6 is a deuterated labeled Prasugrel . Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation .
loading...
    loading...